Other Specialist Resources for Peripheral Vascular Disease
Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.
Evaluating whether drug-coated devices (DCDs) used for femoropopliteal artery revascularization are non-inferior to non-drug-coated devices (NDCDs) in respect to all-cause mortality; assessing the potential for unmeasured confounding; and investigating whether there is consistent safety of DCDs across different patient profiles.
Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.